Links between tropical Pacific seasonal, interannual and orbital variability during the Holocene

The El Niño/Southern Oscillation (ENSO) is the leading mode of interannual climate variability. However, it is unclear how ENSO has responded to external forcing, particularly orbitally induced changes in the amplitude of the seasonal cycle during the Holocene. Here we present a reconstruction of seasonal and interannual surface conditions in the tropical Pacific Ocean from a network of high-resolution coral and mollusc records that span discrete intervals of the Holocene. We identify several intervals of reduced variance in the 2 to 7 yr ENSO band that are not in phase with orbital changes in equatorial insolation, with a notable 64% reduction between 5,000 and 3,000 years ago. We compare the reconstructed ENSO variance and seasonal cycle with that simulated by nine climate models that include orbital forcing, and find that the models do not capture the timing or amplitude of ENSO variability, nor the mid-Holocene increase in seasonality seen in the observations; moreover, a simulated inverse relationship between the amplitude of the seasonal cycle and ENSO-related variance in sea surface temperatures is not found in our reconstructions. We conclude that the tropical Pacific climate is highly variable and subject to millennial scale quiescent periods. These periods harbour no simple link to orbital forcing, and are not adequately simulated by the current generation of models.

Enhanced neural response to anticipation, effort and consummation of reward and aversion during Bupropion treatment

Background We have previously shown that the selective serotonergic re-uptake inhibitor, citalopram, reduces the neural response to reward and aversion in healthy volunteers. We suggest that this inhibitory effect might underlie the emotional blunting reported by patients on these medications. Bupropion is a dopaminergic and noradrenergic re-uptake inhibitor and has been suggested to have more therapeutic effects on reward-related deficits. However, how bupropion affects the neural responses to reward and aversion is unclear. Methods 17 healthy volunteers (9 female, 8 male) received 7 days of bupropion (150 mg/day) and 7 days of placebo treatment, in a double-blind crossover design. Our functional Magnetic Resonance Imaging task consisted of 3 phases; an anticipatory phase (pleasant or unpleasant cue), an effort phase (button presses to achieve a pleasant taste or to avoid an unpleasant taste) and a consummatory phase (pleasant or unpleasant tastes). Volunteers also rated wanting, pleasantness and intensity of the tastes. Results Relative to placebo, bupropion increased activity during the anticipation phase in the ventral medial prefrontal cortex (vmPFC) and caudate. During the effort phase, bupropion increased activity in the vmPFC, striatum, dorsal anterior cingulate cortex and primary motor cortex. Bupropion also increased medial orbitofrontal cortex, amygdala and ventral striatum activity during the consummatory phase. Conclusions Our results are the first to show that bupropion can increase neural responses during the anticipation, effort and consummation of rewarding and aversive stimuli. This supports the notion that bupropion might be beneficial for depressed patients with reward-related deficits and blunted affect.